Immediate Impact
1 from Science/Nature 61 standout
Citing Papers
Lorlatinib Versus Crizotinib in Patients With Advanced ALK -Positive Non–Small Cell Lung Cancer: 5-Year Outcomes From the Phase III CROWN Study
2024 Standout
Targeting immunogenic cell stress and death for cancer therapy
2024 Standout
Works of Carl Barrett being referenced
Abstract LB-192: The A2AR antagonist AZD4635 prevents adenosine-mediated immunosuppression of CD103+ dendritic cells
2019
135O_PR: Plasma genotyping for predicting benefit from osimertinib in patients (pts) with advanced NSCLC
2016
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Carl Barrett | 119 | 46 | 68 | 77 | 23 | 235 | |
| Giacomo Santandrea | 109 | 65 | 42 | 91 | 21 | 261 | |
| Floriana Camarda | 122 | 41 | 40 | 81 | 24 | 201 | |
| Graziana Ronzino | 114 | 48 | 38 | 70 | 20 | 228 | |
| Marit Valla | 98 | 95 | 55 | 102 | 21 | 290 | |
| Koji Nishino | 83 | 38 | 35 | 112 | 20 | 246 | |
| Antonia Wenners | 100 | 73 | 35 | 101 | 21 | 299 | |
| Sotirios Lakis | 121 | 88 | 75 | 73 | 21 | 268 | |
| M K Heatley | 81 | 35 | 30 | 59 | 17 | 249 | |
| Maria M. Rubinstein | 95 | 45 | 39 | 77 | 23 | 271 | |
| Melita Perić Balja | 114 | 29 | 28 | 44 | 28 | 222 |
All Works
Loading papers...